Diagnostic information from a negative QuantiFERON-TB Gold Plus result in adults evaluated for tuberculosis in Brazil and South Africa
In a study of adults with presumptive tuberculosis in Brazil and South Africa, a negative QuantiFERON-TB Gold Plus result provided insufficient diagnostic information to rule out active disease, indicating that such results should not halt further clinical evaluation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Tuberculosis is an ancient and persistent bacterial infection that primarily attacks the lungs. When a person breathes in the bacteria, their immune system often fights back, creating a state of infection where the bacteria hide quietly inside the body without causing immediate sickness. This is different from active tuberculosis, a severe disease where the bacteria multiply and make the person very ill. The medical challenge lies in telling these two states apart, especially when a person shows symptoms that could mean either a hidden infection or a full-blown disease. Doctors rely on blood tests to detect the immune system's reaction to the bacteria, hoping these tests can act as a clear signal to guide treatment. However, a negative result on such a test does not always mean a person is free from the disease, and understanding exactly what a negative result means is crucial for saving lives.
Researchers in Brazil and South Africa set out to examine the reliability of a specific blood test called QuantiFERON-TB Gold Plus when used on adults who were already suspected of having active tuberculosis. These individuals were brought into the study because they showed signs of illness, and doctors needed to know if they had the active disease. The team used the blood test as a primary tool to see if it could help confirm or rule out the diagnosis. They compared the test results against the actual medical reality, which was determined by finding the bacteria in the patient's samples or by identifying a different cause for the symptoms. The goal was to see if a negative result from this test could give doctors enough confidence to stop looking for tuberculosis and move on to other explanations.
The study involved hundreds of adults, and the researchers found that the test did not work as a definitive rule-out tool. Out of the people tested, a small number had results that were too unclear to use, usually because their immune systems did not react strongly enough to the test components. Among those with clear results, the test failed to identify about 32% of the people who actually had active tuberculosis. More importantly, the test was not specific enough to reliably distinguish between those with the disease and those without it. When the researchers calculated the odds, they found that a negative result still left a significant chance that the person was sick. In the context of the study, a negative result meant there was still roughly a thirteen percent probability that the person had active tuberculosis. This means that for every ten people who tested negative, one or two might still be suffering from the disease.
The data also revealed how the test performed in different groups. People living with HIV, a virus that weakens the immune system, were more likely to have unclear test results, yet the test showed higher negative predictive values in this group. This was not because the test became better at detecting the disease in HIV-positive patients, but because the disease was less common in that specific group and the test was better at identifying those who did not have it. The study also looked at a newer version of the test that includes an additional component to detect the bacteria. This addition found a few more cases of tuberculosis, but it also flagged more healthy people as positive, which did not improve the overall ability to rule out the disease.
The final conclusion from this work is straightforward and carries a serious warning for medical practice. A negative result from this blood test does not provide enough information to safely exclude active tuberculosis in adults who are already suspected of having it. Even when the test says the bacteria are not there, the disease could still be present. The researchers emphasize that doctors should not stop their investigation just because the test comes back negative. The diagnostic process must continue, using other methods to ensure that no case of this dangerous disease is missed. The test remains a useful tool for detecting infection, but it cannot be trusted to clear a sick person of active tuberculosis on its own.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.